Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

Mumbai Real Estate Developers Post Strong Q3 Sales, Signal Sustained Homebuyer Confidence
Mumbai Real Estate Developers Post Strong Q3 Sales, Signal Sustained Homebuyer Confidence
How Critical Minerals Are Anchoring India’s Rise To Global Power
How Critical Minerals Are Anchoring India’s Rise To Global Power
Rishabh Pant Extends Warm Wishes To Sanjiv Goenka On His 65th Birthday; Lucknow Super Giants Owner...
Rishabh Pant Extends Warm Wishes To Sanjiv Goenka On His 65th Birthday; Lucknow Super Giants Owner...
Silver Crosses ₹4 Lakh Per Kg In Delhi; Gold Hits Record ₹1.83 Lakh Per 10 Grams
Silver Crosses ₹4 Lakh Per Kg In Delhi; Gold Hits Record ₹1.83 Lakh Per 10 Grams
CII Backs Economic Survey’s Growth Outlook, Urges State To Adopt Entrepreneurial Role
CII Backs Economic Survey’s Growth Outlook, Urges State To Adopt Entrepreneurial Role